Tucatinib 150 Mg Tablet Tucaliv

About Tucatinib 150 Mg Tablet Tucaliv

Product Overview:
Tucatinib 150 mg Tablets are a targeted anti-cancer medication used in the treatment of HER2-positive breast cancer, particularly in advanced or metastatic cases. Tucatinib is a selective tyrosine kinase inhibitor that specifically targets the HER2 receptor, helping to slow the growth and spread of cancer cells while minimizing effects on healthy cells.

Composition:

• Active Ingredient: Tucatinib

• Strength: 150 mg

• Dosage Form: Tablet

Therapeutic Use:

• Treatment of HER2-positive metastatic breast cancer

• Used in combination with other anti-cancer medicines as prescribed by an oncologist

Mechanism of Action:
Tucatinib selectively inhibits the HER2 tyrosine kinase, blocking cancer cell signaling pathways responsible for tumor growth and survival. Its high selectivity helps reduce off-target side effects compared to non-selective HER2 inhibitors.

Key Benefits:

• Targeted HER2 inhibition

• Effective in advanced and metastatic breast cancer

• Suitable for long-term oral therapy

• Clinically proven efficacy when used in combination regimens

Dosage & Administration:

• Dosage should be taken strictly as directed by a qualified oncologist

• Tablets should be swallowed whole with water

• Do not crush or chew

Storage Instructions:

• Store in a cool, dry place

• Protect from light and moisture

• Keep out of reach of children

Packaging:

• Strip / Bottle packing (as available)

Prescription Status:

• Prescription drug (Rx only)

Disclaimer:
This product is intended for use under the supervision of a registered medical practitioner. Dosage and treatment duration depend on the patients clinical condition.

Targeted Therapy for Advanced Breast Cancer

Tucaliv (Tucatinib 150 mg) is designed specifically for patients with HER2-positive metastatic breast cancer. By targeting the HER2 protein, this medication helps reduce cancer growth and progression, potentially improving patient outcomes in those who have previously received other HER2-targeted therapies.


Convenient Oral Administration

Tucaliv comes as a film-coated tablet, meant to be taken orally, offering a non-invasive treatment alternative compared to intravenous therapies. Its easy-to-use formulation allows patients to maintain a consistent therapy routine at home, without frequent hospital visits.


Safe Storage and Long Shelf Life

Packaged in bottles containing 30 tablets, Tucaliv should be stored at temperatures below 30C in its original container to ensure its potency and stability. The product remains effective for up to 24 months, making it practical for both patients and healthcare providers.